Live Analyst Rating Changes 33214 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Derek Jellinek
MORG

Derek Jellinek

Morgans
Wall Street Analyst
★★★☆☆
#1117
on 13Foresight · ranked by our own returns
56%
Success Rate
+4.2%
Average Return
14 of 25 calls profitable · +0.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 56% of Derek Jellinek's ratings turned a profit when each position was held for 1 year — averaging +4.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

25 Buy 12 Hold 0 Sell
Derek's Stock Coverage 11 ratings · 2026-09-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AU:CSL
CSL
 Sep 01, 2026 BUY Strong Buy
+23.0% avg upside
16 analysts
$187.71
6.83% Upside
 +2.3% ·
AU:RHC
Ramsay Health Care
 Aug 28, 2026 HOLD Hold
-13.9% avg upside
14 analysts
$49.39
10.89% Downside
 +9.0% ·
AU:EBR
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
 Aug 26, 2026 BUY Strong Buy
+587.2% avg upside
3 analysts
$1.85
611.57% Upside
 -7.1% ·
AU:ANN
Ansell
 Aug 25, 2026 HOLD Hold
-16.8% avg upside
9 analysts
$37.85
10.53% Downside
 +8.4% ·
AU:SHL
Sonic Healthcare Limited
 Aug 21, 2026 HOLD Hold
+31.2% avg upside
12 analysts
$22.40
16.49% Upside
 -7.3% ·
AU:HLS
Healius Limited
 Aug 20, 2026 HOLD Sell
+124.4% avg upside
10 analysts
$0.43
13.08% Upside
 -16.5% ·
AU:COH
Cochlear
Aug 20, 2026 HOLD Hold
+41.0% avg upside
15 analysts
$138.42
3.29% Upside
 -1.2% ·
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
 Aug 11, 2026 BUY Strong Buy
+26.7% avg upside
11 analysts
$39.50
23.97% Upside
 +1.6% ·
AU:EPI
Epiminder Ltd.
 Aug 03, 2026 BUY Strong Buy
+669.0% avg upside
1 analyst
$2.23
669.01% Upside
 -7.9% ·
AU:SNT
Syntara Limited
 Aug 23, 2023 BUY Strong Buy
+313.0% avg upside
2 analysts
$0.13
465.16% Upside
 -20.0% ·
CSLLY
CSL
 Jun 25, 2019 HOLD Buy
+672.4% avg upside
3 analysts
 — +37.8% ·
🔒 6 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Derek Jellinek — Frequently Asked Questions
How accurate are Derek Jellinek's stock ratings?
Based on the calls 13Foresight could measure, about 56% of Derek's ratings were profitable over a one-year hold, with an average return of +4.7% per rating, or +0.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Derek ranked on 13Foresight?
Derek Jellinek is currently ranked #1117 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Derek cover?
Derek most recently has ratings on AU:CSL, AU:RHC, AU:EBR, AU:ANN, AU:SHL, AU:HLS, AU:COH, AU:RMD, AU:EPI, AU:SNT, CSLLY. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.